SARATOGA SPRINGS — Fingerpaint, biopharma’s global commercialization partner for analytics-enabled integrated solutions, announced that it has acquired MedThink, a North Carolina-based company that empowers healthcare providers through medical communications. Details of the transaction were not disclosed.
The acquisition of MedThink will bring extensive medical communications capabilities to Fingerpaint through 2 distinct divisions: MedThink SciCom, which will harness deep scientific knowledge and extensive industry experience to develop solutions for medical affairs, medical communications and publications groups; and MedThink Communications, which provides medical education and marketing services that influence perception and change the behavior of healthcare professionals to commercial teams of all sizes.
MedThink joins integrated Fingerpaint firms Leaderboard Branding, a leading global naming and branding business; 1798, a market access and commercialization firm that specializes in healthcare consulting services, including patient and provider access services, and Photo 51, a consultancy focused solely on advanced therapeutics, such as gene and cell therapies.
Scott Goudy, president of MedThink, will continue to lead day-to-day operations. GP Bullhound, Inc. acted as financial advisor to MedThink.
